A carregar...
Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis
BACKGROUND: Tolvaptan has been approved in Japan for the treatment of hepatic edema. An important consideration in providing a clinical benefit to patients with liver cirrhosis is the improvement of ascites-related clinical symptoms. In the present post hoc analysis, we aimed to identify factors tha...
Na minha lista:
Publicado no: | J Gastroenterol |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Japan
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5281662/ https://ncbi.nlm.nih.gov/pubmed/27379386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-016-1233-x |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|